ALGS saw its Momentum Indicator move below the 0 level on November 05, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 89 similar instances where the indicator turned negative. In 83 of the 89 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for ALGS turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 45 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALGS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for ALGS entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +9.13% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALGS advanced for three days, in 186 of 237 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
ALGS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Seasonality Score of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 19 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 53 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.797) is normal, around the industry mean (3.498). P/E Ratio (-0.528) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.658) among similar stocks. P/S Ratio (1.680) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. ALGS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALGS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The 10-day RSI Oscillator for SRRK moved out of overbought territory on November 10, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 instances where the indicator moved out of the overbought zone. In 24 of the 25 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SRRK as a result. In 83 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
SRRK moved below its 50-day moving average on November 11, 2026 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for SRRK moved below the 200-day moving average on November 03, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRRK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
SRRK broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for SRRK just turned positive on October 21, 2026. Looking at past instances where SRRK's MACD turned positive, the stock continued to rise in 39 of 49 cases over the following month. The odds of a continued upward trend are 80%.
Following a +13.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where SRRK advanced for three days, in 228 of 286 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 91 of 123 cases where SRRK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 39 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. SRRK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 64 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Valuation Rating of 80 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (22.525) is normal, around the industry mean (3.498). P/E Ratio (-14.181) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.658) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
ALGS | SRRK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 53 Fair valued | 80 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 64 | |
SMR RATING 1..100 | 99 | 99 | |
PRICE GROWTH RATING 1..100 | 95 | 49 | |
P/E GROWTH RATING 1..100 | 19 | 34 | |
SEASONALITY SCORE 1..100 | 12 | 39 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ALGS's Valuation (53) in the null industry is in the same range as SRRK (80) in the Biotechnology industry. This means that ALGS’s stock grew similarly to SRRK’s over the last 12 months.
SRRK's Profit vs Risk Rating (64) in the Biotechnology industry is somewhat better than the same rating for ALGS (100) in the null industry. This means that SRRK’s stock grew somewhat faster than ALGS’s over the last 12 months.
SRRK's SMR Rating (99) in the Biotechnology industry is in the same range as ALGS (99) in the null industry. This means that SRRK’s stock grew similarly to ALGS’s over the last 12 months.
SRRK's Price Growth Rating (49) in the Biotechnology industry is somewhat better than the same rating for ALGS (95) in the null industry. This means that SRRK’s stock grew somewhat faster than ALGS’s over the last 12 months.
ALGS's P/E Growth Rating (19) in the null industry is in the same range as SRRK (34) in the Biotechnology industry. This means that ALGS’s stock grew similarly to SRRK’s over the last 12 months.
| ALGS | SRRK | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 86% | 3 days ago 90% |
| Stochastic ODDS (%) | 3 days ago 87% | 3 days ago 86% |
| Momentum ODDS (%) | 3 days ago 90% | 3 days ago 90% |
| MACD ODDS (%) | 3 days ago 90% | 3 days ago 80% |
| TrendWeek ODDS (%) | 3 days ago 90% | 3 days ago 86% |
| TrendMonth ODDS (%) | 3 days ago 89% | 3 days ago 78% |
| Advances ODDS (%) | 12 days ago 78% | 7 days ago 80% |
| Declines ODDS (%) | 4 days ago 90% | 4 days ago 87% |
| BollingerBands ODDS (%) | 3 days ago 80% | 3 days ago 83% |
| Aroon ODDS (%) | 3 days ago 88% | 3 days ago 74% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALGS’s FA Score shows that 1 FA rating(s) are green while SRRK’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALGS’s TA Score shows that 4 TA indicator(s) are bullish while SRRK’s TA Score has 4 bullish TA indicator(s).
ALGS (@Biotechnology) experienced а -48.40% price change this week, while SRRK (@Biotechnology) price change was -7.96% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -3.38%. For the same industry, the average monthly price growth was -5.88%, and the average quarterly price growth was -18.27%.
ALGS is expected to report earnings on Mar 11, 2027.
SRRK is expected to report earnings on Mar 09, 2027.
Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
A.I.dvisor indicates that over the last year, ALGS has been loosely correlated with ABCL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ALGS jumps, then ABCL could also see price increases.
| Ticker / NAME | Correlation To ALGS | 1D Price Change % | ||
|---|---|---|---|---|
| ALGS | 100% | +6.06% | ||
| ABCL - ALGS | 41% Loosely correlated | -1.12% | ||
| EDIT - ALGS | 40% Loosely correlated | +1.40% | ||
| SRRK - ALGS | 39% Loosely correlated | +0.10% | ||
| AMLX - ALGS | 37% Loosely correlated | +1.44% | ||
| BEAM - ALGS | 35% Loosely correlated | -4.99% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CANE | 11.14 | 0.13 | +1.18% |
| Teucrium Sugar Fund (CANE) | |||
| KNRG | 25.12 | -0.04 | -0.16% |
| Simplify Kayne Anderson Energy And Infrastructure Credit ETF | |||
| IIM | 10.98 | -0.08 | -0.72% |
| INVESCO VALUE Municipal Income TRUST | |||
| JTEK | 90.71 | -1.40 | -1.52% |
| JPMorgan U.S. Tech Leaders ETF (JTEK) | |||
| STXX | 13.18 | -0.89 | -6.33% |
| Tradr 2X Long STX Daily ETF (STXX) | |||